Therapist

A therapist is a licensed mental-health professional — typically a psychologist, counsellor, or social worker — who helps a person process difficult thoughts, emotions, or experiences. In harm-reduction contexts the term most often describes a practitioner with some familiarity with psychedelic or drug-related material, consulted before or after a substance experience to help make sense of what arose.

The phrases integration therapist and psychedelic-informed therapist signal this orientation, but neither corresponds to a regulated credential in most jurisdictions. A clinician using that label is making a claim about personal experience or training interest, not a verifiable qualification separate from their formal licence.

How it is done

Finding a practitioner typically involves a referral, a harm-reduction organisation, or one of the online directories that list psychedelic-adjacent clinicians. Vetting means checking the clinician's formal licence with the relevant regulatory body, asking directly about their experience with drug-related material, and completing an initial consultation before committing to ongoing work.

Sessions are primarily conversational. A person brings an account of an experience — what was disturbing, unresolved, or emotionally persistent — and the therapist works to contextualise it using clinical frameworks. The focus is psychological content: recurring imagery, altered beliefs, mood changes, or difficulty returning to ordinary functioning.

Some practitioners offer preparatory work before a planned experience, helping a person examine intentions and surface existing risk factors. Being present during the experience itself is a distinct arrangement — typically a clinical trial or a licensed therapeutic programme — not standard private practice in most places.

What it cannot tell you

A therapist working from a first-person account cannot establish what substance was actually taken, at what dose, or alongside what else. Memory of an altered state is reconstructive, and pharmacological details — adulterants, actual potency, concurrent drug effects — are not recoverable through conversation.

The psychological relief a person may feel after a productive session does not reduce the pharmacological risks of future use. Integration work addresses what arose in a particular experience; it has no bearing on drug interactions, organ stress, or the probability of a difficult subsequent experience.

The label psychedelic-informed on a clinician's profile is self-reported. It does not indicate training in recognising substance-induced psychiatric symptoms, distinguishing them from primary mental illness, or managing the differential that arises when persistent perceptual changes follow drug use. That territory belongs to addiction medicine and psychiatry. A general therapist — however experienced with integration work — may be operating at the edge of their competence if a presentation moves into it.